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Abstract
Background: Two putative methionine aminopeptidase genes, map (essential) and yflG (non-
essential), were identified in the genome sequence of Bacillus subtilis. We investigated whether they
can function as methionine aminopeptidases and further explored possible reasons for their
essentiality or dispensability in B. subtilis.
Results: In silico analysis of MAP evolution uncovered a coordinated pattern of MAP and
deformylase that did not correlate with the pattern of 16S RNA evolution. Biochemical assays
showed that both MAP (MAP_Bs) and YflG (YflG_Bs) from B. subtilis overproduced in Escherichia
coli and obtained as pure proteins exhibited a methionine aminopeptidase activity in vitro.
Compared with MAP_Bs, YflG_Bs was approximately two orders of magnitude more efficient
when assayed on synthetic peptide substrates. Both map and yflG genes expressed in multi-copy
plasmids could complement the function of a defective map gene in the chromosomes of both E.
coli and B. subtilis. In contrast, lacZ gene transcriptional fusions showed that the promoter activity
of map was 50 to 100-fold higher than that of yflG. Primer extension analysis detected the
transcription start site of the yflG promoter. Further work identified that YvoA acted as a possible
weak repressor of yflG expression in B. subtilis in vivo.
Conclusion: Both MAP_Bs and YflG_Bs are functional methionine aminopeptidases in vitro and in
vivo. The high expression level of map and low expression level of yflG may account for their
essentiality and dispensality in B. subtilis, respectively, when cells are grown under laboratory
conditions. Their difference in activity on synthetic substrates suggests that they have different
protein targets in vivo.
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Ribosome-mediated protein synthesis is always initiated
with either methionine (in eukaryotes) or N-formylme-
thionine (in prokaryotes and eukaryotic organelles) [1].
However, after removal of the N-formyl group from the
polypeptide by peptide deformylase (DEF, EC 3.5.1.88),
the N-terminal methionine of a large number of proteins
is cleaved by methionine aminopeptidase (MAP, EC
3.4.11.18) [2,3]. The efficiency of removal of the initiator
methionine is defined by a highly conserved local sub-
strate specificity, which is determined by both methionine
and its adjacent residue. MAP hydrolytically removes the
N-terminal methionine only when the penultimate resi-
due bears a small and uncharged side chain (Gly, Ala, Ser,
Thr, Pro, Val, or Cys) [4-9], and residues downstream of
the penultimate residue have little impact on the reaction.
All MAPs studied to date were reported to be cobalt-
dependent metalloproteases [3]. However, some reports
showed that MAPs exhibited activity in the presence of
other divalent ions, such as Zn(II), Fe(II) or Mn(II) [10-
12]. According to their sequence homology, MAPs are
grouped into two subtypes, type I and type II [13,14]. An
insertion of approximately 60 residues in the C-terminal
domain of type II methionine aminopeptidases is the
only difference between the two types [14]. Eukaryotes
possess at least two map genes, of both type I and type II
[3], while there is only one map gene in most prokaryotic
genomes, either type I (Archaea) or type II (Bacteria) [15].
MAP is distributed throughout living organisms, where it
plays an important physiological role. The deletion of the
single map gene in prokaryotes such as Escherichia coli [16]
or Salmonella typhimurium [17] is lethal. In yeast, the dele-
tion of any one of the two map genes (type I or type II)
causes a slow growth phenotype, while deletion of both
genes is lethal [18]. Why might MAP activity have an
essential role in living cells? Previous studies showed that
many proteins needed to have their N-terminal methio-
nine removed to have normal biological activity, proper
subcellular localization and eventual degradation
(reviewed in [19]). As a result, it is possible that MAP is
essential because of the essentiality of its downstream tar-
gets. Besides essentiality, MAP changes the dynamics of
the sulfur containing metabolites, which may have an
important role in the homeostasis of the cell.
In general, there is only one map gene in the genome of
prokaryotes, with the exception of a cyanobacteria strain,
which has three functional methionine aminopeptidases
[20]. Surprisingly, in the genomes of Bacilli, two or even
more putative MAP genes can be detected by sequence
alignment. In B. subtilis, two putative genes responsible
for MAP activity, map and yflG, can be identified [21].
Kobayashi et al. [22] reported that map is an essential gene
in B. subtilis while yflG is not, an apparent paradox if yflG
codes for a methionine aminopeptidase. In an attempt to
better understand the functional role of MAP, we studied
the evolutionary trend of MAPs in silico and demonstrated
that both the map and yflG genes from B. subtilis code for
methionine aminopeptidases in vitro and in vivo; further-
more, the finding of a high expression level for map in par-
allel with a low expression of yflG in B. subtilis, may
account for their essentiality and dispensability,
respectively.
Results
Sequence alignment and evolutionary pattern analyses
In the genome sequence of B. subtilis, two genes could
code for methionine aminopeptidases, map and yflG,
respectively [21] (Figure 1). The sequence similarity and
identity between E. coli MAP (MAP_Ec) and B. subtilis
MAP (MAP_Bs) is 65% and 46%, respectively. Similarity
between MAP_Ec and YflG from B. subtilis (YflG_Bs) is
55% and their identity is 34% and similarity between
MAP_Bs and YflG_Bs is 58% and their identity is 36%.
However, the sequence of YflG_Bs differs slightly from the
PROSITE consensus for type I MAPs (PS00680), which is
[MFY]-x-G-H-G- [LIVMC]-[GSH]-x(3)-H-x(4)-[LIVM]-x-
[HN]-[YWVH]. In particular it displays one extra residue
next to the conserved GHG metal-binding motif. Interest-
ingly, MAP_Bs is more similar to MAP_Ec and YflG_Bs is
more similar to the only putative methionine ami-
nopeptidase of Staphylococcus aureus (labelled as "YMAP"
in Figure 1). Overall the proteins are very similar in their
physico-chemical properties (they have closely similar
length and are slightly acidic). Moreover, as shown in Fig-
ure 1, the metal (presumably cobalt) binding site (high-
lighted residues) is conserved. It was therefore important
to investigate whether both proteins had methionine ami-
nopeptidase activity.
This difference in evolution of proteins considered as
essential in related organisms (Firmicutes) is intriguing,
and we explored the evolution pattern of map in a study
meant to identify persistent genes in bacteria [23]. When
matched with the evolution of 16S RNA, the map gene
does not follow a linear course of evolution, as do most
ribosomal proteins [23], but shows an erratic pattern (Fig-
ure 2). This suggests that MAP might be involved in differ-
ent biological processes besides its role as methionine
aminopeptidase according to the organisms. This
prompted us to explore the evolution of MAP with pro-
teins that might be functionally related, using the criteria
we used to identify persistent genes. We defined persistent
genes as the genes present as orthologs in more than 85%
of the genomes of a clade (here 26 Firmicutes), after
removing obligatory endosymbionts from the list (see
Methods). The protein divergence (sequence similarity
divided by sequence length difference) of MAP in B. subti-
lis and its orthologs from other Firmicutes were comparedPage 2 of 15
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rRNA distance). Similar analyses were performed with a
general protease, ClpP, DEF, ribosomal protein S4, RpsD
and YkrB, a second deformylase present in B. subtilis (Fig-
ure 2). Interestingly, in contrast to the expected evolution-
ary pattern of RpsD, MAP exhibited the same erratic
evolutionary way as Def and YkrB, the two functional
deformylases in B. subtilis, suggesting co-evolution of
methionine aminopeptidase and deformylase.
Enzyme activity in vitro
It is often recognized that gene function identification
solely based on sequence comparisons could be mislead-
ing [24,25]. Therefore, we first determined whether map
and yflG were authentic MAP genes by overproducing the
proteins in E. coli and characterizing their enzymatic activ-
ity. Both products of map and yflG genes were purified to
more than 90% homogeneity. Mass spectrometry showed
that the molecular mass of MAP_Bs and YflG_Bs was
27409.17 ± 0.92 Da and 27209.35 ± 2.14 Da, respectively.
Interestingly, both proteins purified from E. coli retained
their initial methionine, consistent with the nature of the
second residue, isoleucine in both cases.
As seen in Table 1, both enzymes exhibited a methionine
aminopeptidase activity in vitro with the synthetic peptide
substrates tested. They differed widely, however, in the
extent of their activity: the specific activity of YflG_Bs was
about 90- and 20-fold higher than that of MAP_Bs with
the tetrapeptide MGMM and tripeptide MAS as the sub-
strates, respectively. Both enzymes preferred the tetrapep-
tide MGMM as the substrate. With MAS and MG as the
substrates, MAP_Bs activity was 76.9% and 46.2% of that
with MGMM as the substrate, respectively, while YflG_Bs
retained only 17.7% and 0.6% relative activity, respec-
tively, with these substrates.
Sequences alignment between MAP from E. coli, B. subtilis, and S. aureusFig re 1
Sequences alignment between MAP from E. coli, B. subtilis, and S. aureus. The first line shows the protein sequence 
of MAP from B. subtilis (MAP_Bs), the second shows MAP from E. coli (MAP_Ec), the third shows YflG from B. subtilis (YflG_Bs) 
and the last shows YflG/MAP from Staphylococcus aureus (YMAP_Sa). Identical amino acids are shadowed in dark and conserva-
tive amino acids are shadowed in grey. The highlighted residues stand for those conserved amino acids important for MAP 
activity (bold and italic residues are conservative basic ones, while bold only are acidic ones). [MFY]-x-G-H-G-[LIVMC]-[GSH]-
x(3)-H-x(4)-[LIVM]-x-[HN]-[YWVH] (where H is a cobalt ligand) is the conserved motif within the protein sequences (placed 
under the alignment).Page 3 of 15
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was investigated (Figure 3). MAP_Bs had significant activ-
ity with both Mn2+ and Co2+. MAP_Bs retained
appreciable activity (26–50%) after replacement of Co2+
with Cd2+, Zn2+, Ca2+, Mg2+, Cu2+, Sr2+ and Ba2+, but not
Ni2+. In contrast, YflG_Bs showed a strong preference for
Co2+ with a decrease in activity to below 20% with any
other divalent ions tested.
Subcellular localization
To investigate whether MAP_Bs and YflG_Bs had any dif-
ference in their subcellular localization, we constructed N-
terminal green fluorescent protein (GFP) fusions of both
proteins. As previously reported, the catalytic domain of
the methionine aminopeptidase is located in the C-termi-
nal part of the polypeptide chain [20,26-29], therefore N-
terminal GFP fusions of both proteins were not expected
to interfere with their functions. In addition, we also con-
structed C-terminal GFP fusions of both MAP_Bs and
YflG_Bs, but because of the possible degradation of the
fusion proteins in vivo or some unknown reasons, we
failed to detect any fluorescence in either case (data not
shown). Cells from strains BSIP8001 (MAP::GFP fusion)
and BSIP8002 (YflG::GFP fusion) in the mid-exponential
growth phase were collected and visualized by fluores-
cence microscopy, respectively. Both GFP-MAP_Bs (Figure
4A) and GFP-YflG_Bs (Figure 4B) proteins distributed
evenly all over the cells. As was expected, the intensity of
the fluorescence of both proteins increased with the
Evolutionary trend analyses of MAP, ClpP, Def, RpsD and YkrBFigure 2
Evolutionary trend analyses of MAP, ClpP, Def, RpsD 
and YkrB. Map, ClpP, Def, RpsD and YkrB were picked up 
from B. subtilis. Their BBHs from other Firmicutes were 
detected. Their protein divergence (sequence similarity 
divided by sequence length difference) in B. subtilis and their 
orthologs from other Firmicutes were compared with bacte-
rial evolutionary distance individually (measured by 16S 
rRNA evolution).
Table 1: Reaction rate of MAP_Bs and YflG_Bs with different 
peptides as the substrates
Specific Activity (U/mg)
Peptide (4 mM) MAP_Bs YflG_Bs
MGMM 2.6 ± 0.3 232.0 ± 8.2
MAS 2.0 ± 0.1 41.0 ± 5.5
MG 1.2 ± 0.1 1.3 ± 0.1
Three measurements for each of the proteins with different 
substrates were made.
Relative activity of (A) MAP_Bs and (B) YflG_Bs in the present of different ionsFigure 3
Relative activity of (A) MAP_Bs and (B) YflG_Bs in 
the present of different ions. MGMM (4 mM) was used as 
the substrate. All ions were tested at 0.2 mM concentration. 
Each of their relative activity was defined as 100% in the 
presence of Co2+ (MAP_Bs: 2.6 U/mg; YflG_Bs: 232.0 U/mg).Page 4 of 15
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sion of the GFP fusions (0.1%- 1% (w/v)) (data not
shown).
MAP-defective mutants are rescued by MAP_Bs or YflG_Bs 
supplied in trans
The E. coli mutant EM9 contains an engineered map gene,
whose expression is under the control of isopropyl β-D-
thiogalactoside (IPTG), so that the strain cannot grow
unless IPTG is added to the growth medium [16]. Using
the replicative vector pBAD, which holds an arabinose-
inducible promoter, the map and yflG genes from B.
subtilis were individually introduced into strain EM9. As
shown in Figure 5, the transformants could complement
the map defect when IPTG was omitted (leading to a MAP
deficiency) if a high concentration of arabinose was sup-
plied, in the case of plasmids carrying either B. subtilis map
or yflG genes. Lower concentrations of arabinose only par-
tially supported growth. This demonstrated that both map
and yflG from B. subtilis can supply the MAP function to E.
coli in vivo.
In B. subtilis, map is an essential gene, while yflG is not
[22]. However, with a back-up map or yflG copy under the
control of IPTG provided in multi-copy plasmid pDG148
(30–50 copies using the pUB110 replicon from B. subtilis
[30]), map::lacZ disruptants in the chromosome of B. sub-
tilis were obtained (BSHP7046 and BSHP7037). Never-
theless, as witnessed in both cases by the systematic
formation of variegated blue white streaked colonies on
X-gal plates, the clones were extremely unstable, leading
to the loss of transformants after a few generations (data
not shown).
map expression is considerably higher than yflG 
expression
The fact that map is essential while yflG is not [22],
together with the ability of yflG gene to rescue MAP_Bs
function when supplied at a high level, points to substan-
tial differences in the expression level of the two genes. To
test this possibility, the expression of map and yflG genes
in B. subtilis in vivo was studied using lacZ as the reporter
gene.
Strains BSHP7042 and BFS4611 were grown in minimal
medium and were used to monitor the expression of map
and yflG, respectively. The map gene showed the higher
promoter activity (Figure 6). Its activity increased gradu-
ally during the log phase of growth and a nearly four-fold
increase was detected (109–379 U/mg) between early
exponential and stationary growth phases. In contrast, the
yflG gene showed very low activity under all the
conditions tested (4–8 U/mg) (Figure 6). In summary, the
map gene promoter showed 50 to 100-fold higher activity
than that of yflG using lacZ as the reporter gene.
Promoter localization of the yflG gene
In the B. subtilis genome, the yflG gene is located upstream
of the yflH gene, followed by a putative Rho-independent
transcription terminator. RT-PCR experiments demon-
strated that yflG and yflH belonged to a common tran-
scription unit, making an operon (data not shown).
Furthermore, lacZ transcription fusion with yflH gene
(strain BSHP7043) showed the same activity changes as
that of yflG gene during all the conditions tested (data not
shown), substantiating the RT-PCR results. In order to
identify the promoter of the yflG-yflH operon, we carried
out primer extension analysis. Two primers complemen-
tary to two different regions inside the yflG gene were used
yielding identification of the same transcription start
Localization of GFP-MAP_Bs and GFP-YflG_Bs fusionsFigure 4
Localization of GFP-MAP_Bs and GFP-YflG_Bs fusions. A. Localization of GFP-MAP_Bs in strain BSIP8001 grown in 
minimal medium with 0.5% xylose (w/v); B. Localization of GFP-YflG_Bs in strain BSIP8002 grown in minimal medium with 1% 
xylose (w/v).Page 5 of 15
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upstream of the ATG translation start codon and regions
weakly similar to consensus -35 (TTCCTA) and -10
(TAAGCT) regions are found upstream of this start point,
separated by 18 nt, in an AT-rich region. It is difficult at
this point to correlate the structure of this promoter with
the poor expression of yflG in all conditions tested.
YvoA showed a slight repression effect on yflG expression
As the expression of yflG in B. subtilis in vivo was very low,
we endeavoured to uncover conditions to enhance its
expression. No significant difference was found when the
carbon, nitrogen and sulfur sources were changed, and no
difference was found in conditions of sporulation or ger-
mination (data not shown). As genes proximal in the
chromosome often code for proteins with related
functions, the neighbourhood of yflG was analysed. Gene
nagP, which encodes a putative phosphoenolpyruvate-
dependent transport system N-acetylglucosamine-specific
enzyme IICB component, is located upstream of yflG and
transcribed divergently (Figure 8A). It could share com-
mon control elements. Exploring the corresponding inter-
genic region with a sliding window 19 nt-long we
uncovered sequence AATTGGTATAGATCACTAG which
has a very significant counterpart (AGCTGGTCTAGAT-
CACTAG) upstream of the nagAB operon, encoding two
N-acetylglucosamine metabolic genes and a putative tran-
scriptional regulator (GntR family) gene, yvoA (Figure
8A). This prompted us to investigate whether YvoA was a
possible regulator for yflG. Using a lacZ fusion, we
Genetic rescue experimentsFigure 5
Genetic rescue experiments. The bacteria were 
streaked on M63 minimal solid medium and the plates were 
incubated at 37°C overnight. The concentration of IPTG was 
1 mM. The order of the plates in each picture described 
below is from left to right and from top to bottom. A. EM9 
host strain on M63 with IPTG; EM9 on M63 without IPTG. B. 
EM9 strain with pBAD vector alone (ECHP1007) on M63 
with IPTG; ECHP1007 on M63 with arabinose (0.5% (W/V)); 
ECHP1007 on M63 without IPTG and arabinose. C. EM9 
strain caring pBAD map vector (ECHP1005) on M63 with 
arabinose (0.5% (W/V)); ECHP1005 on M63 with IPTG; 
ECHP1005 on M63 without IPTG; ECHP1005 on M63 with 
arabinose (0.02% (W/V)); ECHP1005 on M63 with arabinose 
(0.1% (W/V)). D. EM9 strain caring pBAD yflG vector 
(ECHP1006) on M63 with arabinose (0.5% (W/V)); 
ECHP1006 on M63 with IPTG; ECHP1006 on M63 without 
IPTG; ECHP1006 on M63 with arabinose (0.1% (W/V)); 
ECHP1006 on M63 with arabinose (0.02% (W/V)).
Expression of map and yflG lacZ transcriptional fusionsFigure 6
Expression of map and yflG lacZ transcriptional 
fusions. β-galactosidase expression of map and yflG lacZ 
transcriptional fusion during the growth curve of strains 
BSHP7042 and BFS4611 in minimal medium. OD600 (❍) and 
β-galactosidase activity (●) were measured for strain 
BSHP7042 with map lacZ transcription fusion. OD600 () and 
β-galactosidase activity (■) were measured for strain 
BFS4611 with yflG lacZ transcription fusion.Page 6 of 15
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strain, BSIP8004.
As shown in Figure 8B, the promoter of yflG showed a low
but consistently higher activity in the yvoA gene disrupted
strain BSIP8004 when compared with the wild type par-
ent BFS4611 (two-fold higher activity). This suggested
that YvoA could contribute to the regulation of yflG
expression.
Discussion
In prokaryotes, it is usually accepted that there is only one
gene responsible for methionine aminopeptidase. How-
ever, the B. subtilis genome program predicted the
existence of two methionine aminopeptidase genes, map
and yflG [21]. We have shown that both MAP_Bs and
YflG_Bs are functional methionine aminopeptidases in
vitro (Table 1 and Figure 3). Furthermore, gene rescue
experiments showed that both map and yflG genes
expressed on replicative plasmids could supply the MAP
function in E. coli and B. subtilis, demonstrating that both
MAP_Bs and YflG_Bs are functional methionine ami-
nopeptidases in vivo (Figure 5). Interestingly, Kobayashi et
al. [22] reported that disruption of the map gene in B. sub-
tilis is lethal, while the deletion of yflG is not. In the
present study, we obtained B. subtilis map mutants when
map or yflG genes were expressed in multi-copy replicative
plasmids under the control of an IPTG induced promoter
(strains BSHP7046 and BSHP7037). This observation sug-
gests that the single copy of the yflG gene expressed in the
chromosome could not supply the MAP function in B.
subtilis, substantiating that under our conditions its
expression is extremely low, making MAP the only signif-
icant methionine aminopeptidase available. This is
Identification of the transcription start point of the yflG promoterFigure 7
Identification of the transcription start point of the yflG promoter. Primer extension and sequencing reaction were 
performed with the same primer. The size of the extended product is compared to a DNA-sequencing ladder of the corre-
sponding region. An arrow indicates the +1 site. Predicted -10 and -35 regions are in bold and boxed; the experimental tran-
scription start site is in bold; the translational start site is underlined.Page 7 of 15
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map gene is expressed some 50–100-fold higher than yflG
under all conditions tested. Despite the weak expression
of yflG, however, we detected a sigma A promoter using
primer extension (Figure 7). We further showed that this
expression is modulated by YvoA (Figure 8), suggesting a
possible connection between N-acetylglucosamine
metabolism and methionine aminopeptidase. In this
respect it is worth noting that in E. coli glucosamine-6-
phosphate deaminase activity is modulated by the amino-
terminal methionine of the enzyme [31]. We tried several
growth conditions involving N-acetylglucosamine as a
carbon or nitrogen source, or both, but did not find any
modulation of YflG activity (data not shown). We also
explored expression of yflG::lacZ fusions during sporula-
tion and germination. No enhancement was observed
(data not shown). As a consequence, we surmise that the
high expression level of map accounts for its essentiality in
B. subtilis.
The published MAP_Ec activity [6,11] is about 5–10 times
higher than that of MAP_Bs in our assay conditions. This
may be related to the observation that the map gene in E.
coli does not belong to a highly expressed ribosome pro-
tein operon, in contrast to the situation in B. subtilis [32].
As a result, the relative expression level of map in E. coli
might be lower than that of the map gene in B. subtilis. For
still unknown reasons it might be impossible for the yflG
gene to function as the main methionine aminopeptidase
in B. subtilis in vivo in spite of the high activity of YflG_Bs
in vitro. As shown in Table 2, the enzyme activity of MAPs
in crude cell extracts of E. coli (BL5), B. subtilis (168) and
yflG disrupted B. subtilis strain (BFS4611) showed not
much difference in vitro under all the condition tested.
Different expression levels of map genes in a genome car-
rying more than one methionine aminopeptidase genes
have been previously suggested to be the main reason for
their different physiological roles in vivo, but no direct
evidence was provided [20,33]. Methionine
aminopeptidases in vivo are active on proteins, i.e. on
complex polypeptides [34,35] and not on the short pep-
tides in our in vitro assays. It could well be that specific tar-
gets require a specific aminopeptidase. A similar
conclusion holds for other apparently paralogous genes.
For example, there are also two functional peptide
deformylases in B. subtilis, but only one is probably the
predominant deformylase with concomitant high gene
expression [36].
The finding of the co-evolutionary parallel trend of
methionine aminopeptidase and deformylase in Firmi-
cutes (Figure 2) is consistent with functional relationship
in vivo, which correlates well with the fact that deformy-
lase removes all N-formyl groups as a prerequisite for the
subsequent function of MAP [33]. This co-evolution may
be the signature of protein-protein interactions [37,38],
an intriguing conjecture, which seems to be supported by
the consistent duplication of deformylases in genomes
with more than one methionine aminopeptidase (Table
3).
Conclusion
We proved that both MAP_Bs and YflG_Bs are functional
methionine aminopeptidases in B. subtilis and we
Expression of yflG lacZ transcriptional fusions in yvoA dis-ru ted strainFigure 8
Expression of yflG lacZ transcriptional fusions in yvoA 
disrupted strain. A. gene organization around yflG and 
yvoA. The arrows indicate the direction of gene transcription; 
B. β-galactosidase expression yflG lacZ transcriptional fusion 
in yvoA disrupted strain BSIP8004 and yvoA wild type strain 
BFS4611 grown in minimal medium. OD600 (❍) and β-galac-
tosidase activity (●) were measured for strain BSIP8004. 
OD600 () and β-galactosidase activity (■) were measured 
for strain BSIP8004 and strain BFS4611.Page 8 of 15
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expression level, while yflG is nonessential possibly
because of its low expression level making that it can not
take over or compensate the function of map when map is
not expressed, or because of specific targets dedicated to
only one of the two MAPs. Conservation of several map-
like genes in Bacilli suggests involvement in a process
specific to this group of organisms, which may involve
also peptide deformylase.
Methods
Bacterial strains, plasmids, and culture conditions
E. coli and B. subtilis strains as well as plasmids used in this
work are listed in Table 4. E. coli TG1 and XL1-Blue were
used for cloning experiments (TG1 for single cross-over
recombination or replicative plasmids propagation and
XL1-Blue for double cross-over recombination) and E.coli
BL5 for IPTG-induced protein overproducing. B. subtilis
168 was used as the wild type strain in this study. E. coli
cells were grown in Luria-Bertani (LB) medium [39] or in
M63 minimal medium (KH2PO4, 4.4 mM; K2HPO4, 8
mM; (NH4)2SO4, 15 mM; MgSO4, 2 mM; ferric citrate, 34
µM; VitB1, 0.0001% (w/v); fructose, 0.4% (w/v); sodium
citrate, 0.3 mM; CaCl2, 50 µM; MnCl2, 5 µM; ZnCl2, 12 µM;
CuCl2, 2.5 µM; CoCl2, 2.5 µM; Na2MoO4, 2.5 µM)
supplemented with a final concentration of arabinose
from 0.02% to 0.5% (w/v) when needed. B. subtilis cells
were grown in SP medium or in minimal medium
(K2HPO4, 8 mM; KH2PO4, 4,4 mM; glucose, 27 mM; Na3-
citrate, 0.3 mM; L-glutamine, 15 mM; L-tryptophan, 0.244
mM; ferric citrate, 33.5 µM; MgSO4 or L-methionine, 1
mM; MgCl2, 0.61 mM; CaCl2, 49.5 µM; FeCl3, 49.9 µM;
MnCl2, 5.05 µM; ZnCl2, 12.4 µM; CuCl2, 2.52 µM; CoCl2,
2.5 µM; Na2MoO4, 2.48 µM). Antibiotics were added to
the following concentrations when required: ampicillin,
100 µg/ml; spectinomycin, 80 µg/ml; chloramphenicol, 5
µg/ml; phleomycin, 5 µg/ml; kanamycin, 100 µg/ml for E.
coli and 5 µg/ml for B. subtilis. IPTG was added at 1 mM
concentration or as stated when needed. Solid media were
prepared by adding 1.5% agar (w/v) to the respective liq-
uid media. Bacteria were grown at 37°C. The optical den-
sity (OD) of bacterial cultures was measured at 600 nm.
All experiments were performed in accordance with the
European regulation requirements concerning the con-
tained use of Genetically Modified Organisms of Group-I
(French agreement N° 2735).
DNA techniques
DNA purification, restriction enzyme digestion, ligation
and transformation of E. coli were performed according to
standard protocols [40]. For cloning purpose, YieldAce or
Pfu DNA polymerase (Stratagene) was used. All the DNA
sequences in the plasmids constructed in this work were
determined using the dideoxy-chain termination method
and Thermo Sequenase Kit (Amersham Pharmacia
Biotech). B. subtilis cells were transformed with plasmid
DNA following the two-steps protocol described previ-
ously [41]. Transformants were selected on LB plates con-
taining corresponding antibiotics and IPTG when needed.
Plasmid and strain constructions
In order to clone the genes from B. subtilis for protein pro-
ducing in E. coli, both map and yflG genes were amplified
by PCR from genomic DNA of B. subtilis 168 and cloned
into expression vector pET24b(+) (Novagen) using NdeI
and XhoI restriction sites. The amplified fragments
included nucleotides +1 to +744 and nucleotides +1 to
+747 relative to the translational start point of map and
yflG, respectively. The resulting constructs, plasmids
pIPP8003 and pIPP8004, were transformed into E. coli
BL5 giving strains ECIP8003 and ECIP8004 for overpro-
ducing MAP and YflG, respectively.
To construct map and yflG GFP fusion plasmids and
strains, both map and yflG genes were amplified by PCR
from genomic DNA of B. subtilis 168 and cloned into N-
terminal GFP fusion vector pSG1729 [42] using XhoI and
EcoRI restriction sites. The amplified fragments included
nucleotides +1 to +744 and nucleotides +1 to +747
relative to the translational start point of map and yflG,
respectively. The resulting plasmids, pIPP8001 and
pIPP8002, were linearized by the ScaI restriction enzyme
and were transformed into B. subtilis 168. Clones were
Table 2: MAP activity in crude cell extracts of E. coli and B. subtilis
Specific Activity (U/mg)
Peptide (4 mM) E. coli (BL5) B. subtilis wild type (168) B. subtilis yflG mutant (BFS4611)
MGMM 1.5 ± 0.2 1.5 ± 0.1 1.5 ± 0.1
MAS 1.1 ± 0.2 1.1 ± 0.1 1.1 ± 0.2
MG 0.6 ± 0.1 0.8 ± 0.2 0.4 ± 0.1
Cells in stationary growth phase of each of the strains were collected and sonically disrupted. Supernatants of each of the cell debris were used to 
measure MAP activity. Totally, three times of measurements were carried out.Page 9 of 15
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cross-over recombination at amyE site [42], giving strains
BSIP8001 and BSIP8002, respectively.
To obtain map and yflG expression plasmids for further
map gene rescue analysis in a conditional map gene dele-
tion E. coli strain, EM9 [16], both map (nucleotides -30 to
+744 relative to the map translation start point) and yflG
(nucleotides -21 to +754 relative to the yflG translation
start point) genes were amplified by PCR from genomic
DNA of B. subtilis 168 with the creation of BamHI and
BglII sites. Both purified PCR fragments were cleaved by
BamHI and BglII restriction enzymes and inserted
between the same two sites in plasmid pBAD containing
arabinose inducible promoter (a modified pBAD-αβγ
plasmid containing an additional BamHI cloning site was
used after removing a BamHI and BglII insert [43]), pro-
ducing plasmids pHPP1017 and pHPP1018, respectively.
The proper orientation was checked by the ability of
cloned fragment to be recovered by double digestion
using BamHI and BglII restriction enzymes. Plasmids
pHPP1017, pHPP1018 and the pBAD vector were trans-
formed into E. coli strain EM9 individually and selected
on LB plates containing ampicillin, chloramphenicol and
IPTG, giving strains ECHP1005, ECHP1006 and
ECHP1007, respectively.
To obtain a back-up map and yflG copies for further con-
ditional map disruptant construction in B. subtilis, the map
gene (nucleotides -43 to +744 relative to the map transla-
tion start point) and yflG gene (nucleotides -54 to 733 rel-
ative to the yflG translation start point) was amplified by
PCR from genomic DNA of B. subtilis 168 using primers
introducing a SalI cloning site at the 5' end and a SphI
cloning site at the 3' end, respectively. Both fragments
were then inserted into the SalI and SphI sites of the IPTG-
inducible replicative vector pDG148 [44], producing
plasmid pHPP7021 and pHPP7022, respectively. The
wild type strain B. subtilis 168 was transformed with these
plasmids, giving strains BSHP7045 and BSHP7038,
respectively.
To disrupt the map gene, a 246 bp-long fragment within
the map gene (nucleotides +142 to +388 relative to the
map translation start point) was amplified by PCR from
genomic DNA of B. subtilis 168 using primers introducing
an EcoRI cloning site at the 5' end and a BamHI cloning
site at the 3' end of the fragment. This fragment was then
inserted into the EcoRI and BamHI sites of plasmid
pJM783 [45], which contains a promoterless lacZ reporter
gene, producing plasmid pHPP7025. The plasmid was
introduced into the chromosome of BSHP7045 and
BSHP7038 strains by a single cross-over event, giving
strains BSHP7046 and BSHP7037, respectively. To ascer-
tain that they were correctly inserted, clones were checked
by PCR.
To construct a map transcriptional fusion with the lacZ
gene, a DNA fragment downstream from the map gene
(nucleotides from + 423 relative to the translation start
point to the gene's stop codon) was amplified by PCR
from genomic DNA of B. subtilis 168 using primers intro-
ducing an EcoRI cloning site at the 5' end and a BamHI
cloning site at the 3' end of the fragment, then inserted
into the EcoRI and BamHI sites of plasmid pJM783 [45],
producing plasmid pHPP7017. The plasmid was intro-
Table 3: Distribution of def and map genes in selected genomes
Numbers in Each Genome
Genome Name def map EMBL ID
Streptomyces coelicolor 4 3 AL645882
Streptomyces avermitilis 3 4 BA000030
Nocardia farcinica IFM 10152 3 3 AP006618
Shewanella oneidensis MR-1 3 1 AE014299
Silicibacter pomeroyi DSS-3 3 1 CP000031
Bacillus cereus ZK 2 3 CP000001
Bacillus thuringiensis serovar konkukian 2 3 AE017355
Bacillus anthracis 'Ames Ancestor' 2 3 AE017334
Bacillus anthracis Sterne 2 3 AE017225
Bacillus cereus ATCC 10987 2 3 AE017194
Bacillus anthracis Ames 2 3 AE016879
Bacillus cereus ATCC 14579 2 3 AE016877
Leifsonia xyli subxyli CTCB07 2 3 AE016822
Synechocystis PCC 6803 1 3 BA000022
Bacillus clausii KSM-K16 1 3 AP006627Page 10 of 15
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crossover event, giving strain BSHP7042.
The yflG transcriptional fusion with the lacZ gene
(yflG::lacZ disruptant, strain BFS4611) was constructed
within the framework of the European Union and Japa-
nese project for the functional analysis of the genome of
B. subtilis, where more than 2000 genes have been dis-
rupted by fusion with lacZ reporter gene [22,46,47].
To construct a yflH transcriptional fusion with the lacZ
gene, a DNA fragment downstream from the yflH gene
Table 4: Bacterial strains and plasmids used or created in this study
Strains Genotype Source or Reference
Escherichia coli
XL1-Blue K12 supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac- F'[proAB+ lacIq lacZ∆M15 Tn10(tetR)] Laboratory collection
TG1 K12 supE hsd∆5 thi ∆ (lac-proAB) F'[traD36 proA+ proB+ lacIq lacZ∆M15] Laboratory collection
BL5(DE3) F- Invitrogen
EM9 PT7-map (on chromosome) Chiron Culture Collection Centre
ECIP8003 F- pIPP8003 This work
ECIP8004 F- pIPP8004 This work
ECHP1005 EM9 pHPP1017 This work
ECHP1006 EM9 pHPP1018 This work
ECHP1007 EM9 pBAD This work
Bacillus subtilis
168 trpC2 Laboratory collection
BFS4611 trpC2 yflG::lacZ Functional analysis projecta
BFS817 trpC2 yvoA::lacZ Functional analysis projecta
BSHP7042 trpC2 map-lacZ This work
BSHP7045 trpC2 pDG148-map This work
BSHP7046 trpC2 map::lacZ pDG148-map This work
BSHP7037 trpC2 map::lacZ pDG148-yflG This work
BSHP7038 trpC2 pDG148-yflG This work
BSHP7043 trpC2 yflH::lacZ This work
BSIP8001 trpC2 amyE::gfp-map This work
BSIP8002 trpC2 amyE::gfp-yflG This work
BSIP8003 trpC2 yvoA::[(lacZ-ery)::pEC23(Kan)] This work
BSIP8004 trpC2 yflG::lacZ yvoA::[(lacZ-ery)::pEC23(Kan)] This work
Plasmids Description Source or Reference
pET24b(+) expression vector, KanR Novagen
pBAD-abg genetic rescue vector, AmpR [43]
pDG148 expression vector, AmpR KanR [44]
pJM783 cloning vector, CmR [45]
pSG1729 N-terminal GFP fusion vector, AmpR SpecR [42]
pEC23 integrative plasmid, KanR M. Simon and P. Stragier, unpublished
pIPP8003 pET24b map This work
pIPP8004 pET24b yflG This work
pHPP1017 pBAD map This work
pHPP1018 pBAD yflG This work
pHPP7017 pJM783 map-lacZ This work
pHPP7018 pJM783 yflH::lacZ This work
pHPP7021 pDG148 map This work
pHPP7022 pDG148 yflG This work
pHPP7025 pJM783 map::lacZ This work
pIPP8001 pSG1729 map This work
pIPP8002 pSG1729 yflG This work
a This strain has been constructed during the frame of the project for the functional characterization of the genome of B. subtilis in Japan [46].Page 11 of 15
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start point) was amplified by PCR from genomic DNA of
B. subtilis 168 using primers introducing an EcoRI cloning
site at the 5' end and a BamHI cloning site at the 3' end of
the fragment, then inserted into the EcoRI and BamHI sites
of plasmid pJM783 [45], producing plasmid pHPP7018.
The plasmid was introduced into the chromosome of B.
subtilis 168 by a single cross-over event, giving strain
BSHP7043.
To obtain the disruptant yvoA strain compatible with
BFS4611, the BFS817 strain (yvoA::lacZ disruptant, from
the European Union and Japanese consortium, see above)
was transformed with the ScaI linearized pEC23 plasmid
(which carries a kanamycin resistance gene, M. Simon and
P. Stragier, unpublished) for replacement with the kan-
amycin resistance gene of the lacZ and Erm genes belong-
ing to the pMutin plasmid (erythromycin resistant)
integrated into the genome, by homologous recombina-
tion. The resulting clones were checked for their inability
to grow on erythromycin and chloramphenicol. The
resulting strain was named BSIP8003. The chromosomal
DNA of BSIP8003 was prepared and used to transform the
BFS4611 strain, producing the double yvoA and yflG dis-
rupted strain BSIP8004.
Expression and purification of MAP_BS and YflG_Bs 
proteins
The strains ECIP8003 and ECIP8004 were grown at 37°C
in LB medium containing kanamycin (25 µg/ml) and
induced with 0.5 mM IPTG for four hours. Cell pellets
were harvested by centrifugation and stored at -20°C.
Cells were suspended in 20 mM Tris-HCl (pH 8.0) and
sonically disrupted. The cellular debris was removed by
centrifugation at 12,000 g for 40 min. The supernatants
were applied to a DEAE-sephacel column chromatogra-
phy (Amersham). The protein (MAP_Bs or YflG_Bs) was
eluted with 0.1 M NaCl in the same buffer. Protein con-
centration was determined by the Bradford's method [48]
using protein assay kit (Bio-Rad Laboratories). The purity
of isolated proteins was determined by SDS-PAGE [40].
Ion mass spectrometry was used to measure the molecular
mass of each purified protein as well as checking the exist-
ence of the first methionine in each of the proteins.
Enzyme assays
The methionine aminopeptidase assay was performed as
described by Arie Ben-Bassat et al. [6] with small modifi-
cations. 10 µl protein solution was added to 90 µl of the
substrate solution (4 mM peptide in 0.1 M K2HPO4
(pH7.5), and 0.2 mM CoCl2), then incubated at 37°C for
10 min. The reaction was stopped by incubation at 100°C
for 2 min. After addition of 900 µl of the colour
development mixture (containing 0.2 mg of L-amino acid
oxidase, 0.03 mg of horseradish peroxidase, and 0.2 mg of
o-dianisidine dihydrochloride in 0.1 M Tris-HCl (pH
7.4)), the tube was incubated at 37°C for 10 min, then the
absorbance at 440 nm was recorded. Standard curve with
known concentration of L-methionine in the colour
development buffer was plotted for quantitative analysis.
The absorbance of 1 µmol of methionine per ml at 440
nm is equivalent to 8.6 [6]. One Unit of activity was
defined as 1 µmol of methionine produced per min under
the assay conditions used. Preference of metal ions was
tested by changing the cobalt in the substrate solution
into other divalent metal ions at a final concentration of
0.2 mM.
Amylase activity was detected after growth of B. subtilis
strains on Tryptose Blood Agar Base (TBAB, Difco) supple-
mented with 10 g/l hydrolyzed starch (Sigma). Starch
degradation was detected by sublimating iodine onto the
plates [49].
β-galactosidase specific activity was measured as described
by Miller [50]. One Unit of β-galactosidase activity was
defined as the amount of enzyme that produced 1 nmol
of o-nitrophenol per min at 28°C. Specific activity was
expressed in Units per mg protein. The experiments were
performed in triplicates.
Subcellular localization analysis
To visualize GFP-MAP_Bs and GFP-YflG_Bs fusions loca-
tions in living cells, BSIP8001 and BSIP8002 strains were
grown in minimal medium with 0.5% fructose as the sole
carbon source supplemented with xylose to different final
concentrations (0.1% to 1% (w/v)). Cells from the mid-
exponential growth phase were collected and visualized
by fluorescence microscopy. Microscope Axiovert 135 TV
(ZEISS, Germany) was used in the experiment and fluo-
rescence filter sets used to visualize GFP were obtained
from Chroma Technology Corp (USA). Cells were visual-
ized on 1% agarose (w/v) slides [51] using Axiovision 4
system (Allied High Tech Products, Inc.) with exposure
time of 3–10 s.
Genetic rescue experiment
The growth of EM9, ECHP1005 (containing B. subtilis map
gene), ECHP1006 (containing B. subtilis yflG gene) and
ECHP1007 (containing pBAD vector alone), was
compared on M63 minimal medium plates (37°C, over-
night) in the presence or absence of IPTG (1 mM) with or
without arabinose (0.02 %, 0.1 % and 0.5 %).
RNA isolation and manipulation
Total cellular RNA was extracted from B. subtilis 168 cells
growing in minimal medium to an OD600 of 0.5 using
High Pure RNA Isolation Kit from Roche. The RNA con-
centration was determined by light absorption at 260 nm
and 280 nm. 2 µg of RNA were loaded onto 1.2% agarosePage 12 of 15
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ments were performed using RT-PCR System (Promega)
as specified by the manufacturer.
Primer extension analysis was carried out using reverse
transcriptase AMV (Roche) as described [52]. Two oligo-
nucleotides (+33 to +62 and +97 to +126 relative to trans-
lation start point of yflG) were used for the identification
of yflG promoter. The same primers were used for the gen-
eration of sequence ladders. Reaction products were
separated on 7% denaturing polyacrylamide gel contain-
ing 8 M urea. DNA sequences were determined using
Sanger's dideoxy chain-termination method with
"Thermo Sequenase radiolabeled terminator cycle
sequencing kit" from Amersham Pharmacia Biotech.
DNA sequence and in silico analysis
DNA sequences were analyzed using the DNA Strider soft-
ware [53]. The program BLAST [54] was used to search for
homologous sequences in the database. The program
CLUSTALW was used for multiple alignment [55]. B. sub-
tilis sequences were analyzed using the SubtiList database
[56,57]. Accepted consensus sequences were extracted
from PROSITE [58,59].
Evolutionary pattern analyses
First, MAP orthologs (orthologs were defined using the
BBH (Bi-directional Best Hit) strategy, i.e. if gene a of
genome A is the most similar hit of gene b in genome B
and vice versa, gene a and b are regarded as a pair of
orthologs [60]) were retrieved between each pair of bacte-
rial genomes. Secondly, the BBHs, with protein sequence
similarity >50% and protein length difference <1.3, of the
gene map in B. subtilis were collected. Thirdly, the
orthologs of each of the BBHs were collected in all the
genomes (a total of 206 bacterial genomes in EMBL as of
July 1st, 2005), after recursive identification until the
members in this cluster is no longer extended. Last, the
protein divergence (sequence similarity divided by
sequence length difference) of MAP in B. subtilis and its
orthologs from other Firmicutes were compared with bac-
terial evolutionary distance (measured by 16S rRNA
evolution). Same analyses were carried out on ClpP, Def,
RpsD and YkrB.
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